Cephalexin

Cephalexin is the first oral first-generation cephalosporin to enter widespread clinical use, effective against Gram-positive pathogens for skin, soft-tissue and urinary tract infections. Simson Pharma's Cephalexin reference standard and impurities support the high-volume compendial testing this long-established generic antibiotic demands.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cephalexin Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Cephalexin Monohydrate
Cefalexin EP Impurity A
Cefalexin EP Impurity B
Cefalexin EP Impurity D
Cefalexin EP Impurity F Trifluoroacetate
Cefalexin EP Impurity C
Cefalexin EP Impurity E
Cephalexin Sulfoxide
Cephalexine RC K
Cephalexine RC D
Cefalexin EP Impurity F
L-Cephalexin
D-Phenylglycinamide
Cephalexin Diketopiperazine Hydrochloride
Cefalexin Diketopiperazine
Cephalexin R-Sulfoxide Hydrochloride
Cephalexin S-Sulfoxide
Chloro Cephalexin
3-Hydroxy-4-methyl-2(5H)-thiophenone
Cephalexin Diketopiperazine Monoacid
Delta-2-Cephalexin triethylamine salt
Cefalexin Impurity 5
Cefalexin Amide Impurity
Cefalexin Impurity 6
Cefalexin Diketopiperazine Delta-3 Isomer
Cephalexin Diketopiperazine Sodium Salt
L-Cephalexin Trifluoroacetate
Cefalexin R-Sulfoxide
Deacetylcephalosporin C
Cephalexin Dimer
Cephalexin Ethyl Homolog

Isotope Labelled Compounds

Cephalexin D5 Monohydrate